Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas bought 132,572 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was bought at an average price of $0.49 per share, with a total value of $64,960.28. Following the completion of the purchase, the chief executive officer now directly owns 4,029,588 shares in the company, valued at $1,974,498.12. This represents a 3.40 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website.
Grigorios Siokas also recently made the following trade(s):
- On Monday, February 24th, Grigorios Siokas bought 354,296 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.56 per share, for a total transaction of $198,405.76.
- On Thursday, January 30th, Grigorios Siokas acquired 51,414 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.66 per share, for a total transaction of $33,933.24.
- On Wednesday, January 22nd, Grigorios Siokas bought 38,900 shares of Cosmos Health stock. The stock was purchased at an average price of $0.77 per share, for a total transaction of $29,953.00.
- On Friday, January 17th, Grigorios Siokas acquired 29,158 shares of Cosmos Health stock. The stock was acquired at an average price of $0.86 per share, for a total transaction of $25,075.88.
- On Wednesday, January 15th, Grigorios Siokas purchased 62,500 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.80 per share, for a total transaction of $50,000.00.
- On Monday, January 13th, Grigorios Siokas bought 163,666 shares of Cosmos Health stock. The stock was bought at an average price of $0.61 per share, for a total transaction of $99,836.26.
- On Friday, December 20th, Grigorios Siokas purchased 257,334 shares of Cosmos Health stock. The shares were bought at an average price of $0.58 per share, with a total value of $149,253.72.
Cosmos Health Stock Performance
Cosmos Health stock traded up $0.01 during mid-day trading on Tuesday, hitting $0.50. The company had a trading volume of 266,621 shares, compared to its average volume of 581,515. The company has a current ratio of 1.44, a quick ratio of 1.24 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $11.72 million, a price-to-earnings ratio of -0.21 and a beta of 5.60. The company’s fifty day moving average is $0.68 and its 200-day moving average is $0.80. Cosmos Health Inc. has a 12-month low of $0.44 and a 12-month high of $1.58.
Institutional Trading of Cosmos Health
About Cosmos Health
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Recommended Stories
- Five stocks we like better than Cosmos Health
- What is a Low P/E Ratio and What Does it Tell Investors?
- GitLab: Get In While It’s Down—Big Rebound Ahead
- What does consumer price index measure?
- Tesla Stock: Finding a Bottom May Take Time
- P/E Ratio Calculation: How to Assess Stocks
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.